Palantir’s Two-Speed Story: U.S. Boom vs. European Backlash Leaves Stock Stuck in No Man’s Land

Palantir's US revenue surged 85% in Q1 2026, but European governments are cutting ties over data sovereignty. Can American momentum support a €264B valuation?

Palantir Technologies is living a double life. In the United States, the data-analytics firm has become an indispensable cog in the national security apparatus, with the government and commercial engines firing on all cylinders. Across the Atlantic, however, a coordinated retreat is underway. European governments are actively cutting ties, citing digital sovereignty, while the stock trades roughly 20% below where it started the year. The question for investors is whether America’s momentum alone can sustain a market value of €264 billion.

U.S. growth is staggering — for now

The numbers from Palantir’s first quarter of 2026 are extraordinary. Total revenue jumped 85% year-on-year to $1.63 billion, the fastest expansion since its public listing. The U.S. commercial segment was the standout, with revenue surging 133% compared with the same period last year. Government contracts continue to pile up: the Army, Space Force, Treasury Department, and the Department of Homeland Security — which inked a framework deal worth up to $1 billion over five years — have all deepened their commitments. The Pentagon has embedded Palantir’s Maven AI system as a permanent military platform. Roughly 55% of total revenue now flows from government sources, a dependence the company calls strategic entrenchment.

Buoyed by that pipeline, management raised full-year guidance. Revenue is now expected to reach between $7.65 billion and $7.66 billion — an implied growth rate of 71% — while free cash flow is projected to hit as much as $4.4 billion.

Europe pushes back

The European picture is starkly different. France has decided to replace Palantir’s AI tools with a domestic provider, explicitly citing the need to avoid “strategic dependency” on US technology. Germany is likewise pulling back. Even in Britain, where contracts with the Ministry of Defence and the NHS total over £900 million, political headwinds are building: an NHS contract is under review, and a planned deal with the Metropolitan Police in London was blocked.

This is not a series of isolated hiccups. It reflects a deliberate policy shift across the continent toward data sovereignty and homegrown alternatives. For Palantir, the implication is clear: future growth will be overwhelmingly American, and the question is whether the US market is large enough to offset the gradual erosion of its European footprint.

Analysts see upside — but with caveats

UBS remains bullish, with analyst Karl Keirstead reiterating a buy rating and a $200 price target. Baird also affirmed its positive stance after meeting with Palantir’s management. The consensus among analysts stands at €157.61, implying roughly 37% upside from current levels. But the range of individual targets is unusually wide, reflecting deep disagreement over how to weigh rapid growth against geopolitical risk and a stretched valuation.

Competition is another concern. Heavyweights such as OpenAI, Anthropic, and Databricks are developing their own data and context layers that closely resemble Palantir’s core architecture. The company argues that pure language-model providers will struggle to penetrate deeper data tiers, but investors want hard proof that customers will stick with Palantir’s expensive software amid a wave of new AI options.

Technicals tell a cautious story

Despite the operational strength, the stock has been a laggard. At €114.42, it stands well below its 200-day moving average of €137.29 and roughly 36% off the 52-week high of around €180 hit in November 2025. Annualized 30-day volatility exceeds 53%, signaling that the market is pricing in considerable uncertainty. For the bulls, the U.S. growth trajectory and the UBS price target offer a compelling narrative. For the bears, Europe’s backlash, the rise of AI rivals, and a valuation that still demands perfection are reasons to wait on the sidelines. Right now, Palantir’s share price is caught between two worlds — and neither is giving ground.